| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2018 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 40,000 | $38.25 | $1,530,000.00 | -25.0% | |
| Jan 18, 2018 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 21,850 | $72.50 | $1,584,125.00 | -6.7% | |
| Jan 18, 2018 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 3,120 | $38.12 | $118,934.40 | -2.5% | |
| Jan 17, 2018 | IQV Iqvia Holdings Inc. | Erlinger III James H | See Remarks | Sell | 10,000 | $99.97 | $999,700.00 | -42.6% | |
| Jan 12, 2018 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 125,402 | $52.79 | $6,620,592.75 | -6.9% | |
| Jan 12, 2018 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 13,759 | $36.25 | $498,763.75 | -10.3% | |
| Jan 5, 2018 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 43,703 | $70.00 | $3,059,210.00 | -12.6% | |
| Jan 3, 2018 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 1,665 | $52.54 | $87,474.11 | -3.9% | |
| Jan 2, 2018 | WAT Waters Corp /de/ | Reed Joann A47 | Director | Sell | 1,386 | $194.07 | $268,981.02 | -6.6% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 5,486 | $109.53 | $600,891.44 | -0.7% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Bertolini Robert J | Director | Sell | 3,609 | $110.22 | $397,784.52 | -0.6% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 7,322 | $109.78 | $803,822.53 | - | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 8,231 | $110.01 | $905,497.03 | -1.4% | |
| Jan 2, 2018 | WAT Waters Corp /de/ | Berendt Michael J54 | Director | Sell | 3,500 | $194.58 | $681,030.00 | -13.0% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,246 | $110.16 | $1,018,557.79 | -0.1% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Bertolini Robert J | Director | Sell | 4,131 | $109.59 | $452,717.16 | -0.5% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,465 | $110.31 | $382,229.16 | - | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 3,100 | $110.38 | $342,191.00 | -1.6% | |
| Jan 2, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,967 | $109.44 | $543,589.69 | - | |
| Dec 28, 2017 | XWEL Xwell, Inc. | Awm Investment Company, Inc.73 | 10% Owner | Sell | 110,000 | $1.52 | $167,548.64 | -1.4% | |
| Dec 22, 2017 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 123,512 | $52.58 | $6,494,789.57 | -6.8% | |
| Dec 21, 2017 | XWEL Xwell, Inc. | Awm Investment Company, Inc.73 | 10% Owner | Sell | 200,000 | $1.50 | $300,110.00 | -3.4% | |
| Dec 21, 2017 | PRPH Prophase Labs, Inc. | Karkus Ted William | CEO &Chairman | Sell | 424,789 | $2.30 | $977,014.70 | -14.6% | |
| Dec 20, 2017 | IQV Iqvia Holdings Inc. | Erlinger III James H | See Remarks | Sell | 10,000 | $101.21 | $1,012,100.00 | -38.1% | |
| Dec 20, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $9.96 | $49,780.00 | -1.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.